HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB: PWRM, https://www.power3medical.com), a leading proteomics company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases, presented a scientific poster at the San Antonio Breast Cancer Symposium. Dr. Essam Sheta, one of the authors of the poster, a Director of Power3’s CLIA laboratory and Director of Biochemistry, presented the poster for the company.
